8-K: OneWater Marine Sells Ocean Bio-Chem for $50M, Cuts Debt

Sentiment:

Asset Disposition 6 February 2026 4:07 PM

OneWater Marine Inc. has completed the sale of its Ocean Bio-Chem Holdings, Inc. subsidiary for an estimated $50 million, using the proceeds to reduce outstanding debt.

Summary

OneWater Marine Inc. (the Company) completed the sale of its equity interests in Ocean Bio-Chem Holdings, Inc. to Recochem Inc. on February 2, 2026.
The estimated cash purchase price for the transaction was approximately $50.0 million, derived from a base price of $55.0 million less an estimated $5.0 million in working capital and other adjustments.
A final working capital true-up will be determined 120 days after the closing date.
Proceeds from the sale will be used to repay a portion of the Company's outstanding debt.
The transaction resulted in an estimated non-recurring pro forma net loss on sale of $8.939 million, calculated from $50.0 million cash received (net of expenses) minus $59.571 million carrying value of assets/liabilities, plus a $632 thousand deferred tax benefit.
Pro forma financial statements indicate that for the year ended September 30, 2025, the elimination of Ocean Bio-Chem's operations would have reduced total revenues by $61.460 million and total cost of sales by $39.391 million.
Selling, general and administrative expenses would have decreased by $20.754 million, and depreciation and amortization by $4.074 million.
The pro forma net loss attributable to OneWater Marine Inc. for the year ended September 30, 2025, would have improved by $1.951 million as a result of the transaction.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive strategic move. While there is a one-time accounting loss on the sale, the use of proceeds for debt reduction and the pro forma improvement in the company's net loss indicate a stronger, more focused core business going forward.

Positives

The Company used the $50.0 million in cash proceeds from the sale to repay a portion of its outstanding debt, strengthening its balance sheet.
The pro forma financial statements indicate an improvement in net loss attributable to OneWater Marine Inc. by $1.951 million for the year ended September 30, 2025, suggesting a positive impact on the profitability of the remaining core business.
The disposition of Ocean Bio-Chem allows OneWater Marine to streamline its operations and potentially focus on its core marine retail business.

Negatives

The transaction resulted in an estimated non-recurring pro forma net loss on sale of $8.939 million.
The Company will see a reduction in total revenues by $61.460 million and total cost of sales by $39.391 million on a pro forma basis for the year ended September 30, 2025, due to the divestiture.

Risks

Forward-looking statements are not guarantees of future performance and are subject to uncertainties, risks, and changes in circumstances that are difficult to predict.
Actual adjustments to the purchase price, particularly the final working capital true-up, may differ materially from the estimated $5.0 million reduction.
The Company's ability to achieve potential future cost savings mentioned in the pro forma statements is not guaranteed and may not materialize.

Future Outlook

The filing contains standard forward-looking statements cautioning that expectations, assumptions, and beliefs concerning future developments and their potential effect are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. It explicitly states that expectations expressed or implied in these statements may not turn out to be correct and that the company undertakes no obligation to update or revise them.

Industry Context

StockSavvy.ai notes that the divestiture of Ocean Bio-Chem Holdings, Inc., a manufacturer and distributor of specialty chemical and engine maintenance products, by OneWater Marine Inc., a leading marine retailer, represents a strategic move towards focusing on its core business. This aligns with a broader industry trend where companies shed non-core assets to improve operational efficiency, reduce debt, and enhance shareholder value by concentrating on areas of competitive advantage. Competitors in the marine retail sector may view this as a positive step for OneWater Marine to streamline its portfolio and strengthen its financial position, potentially allowing for greater investment in its primary retail operations or future acquisitions within its core segment.

Comparison to Industry Standards

The use of sale proceeds to repay outstanding debt is a common and generally well-regarded financial strategy, especially in industries that can be cyclical or capital-intensive like marine retail, as it improves financial leverage and reduces interest expense.
The estimated non-recurring loss on sale of $8.939 million is a one-time accounting impact. Strategic divestitures often involve such losses if the carrying value of the divested asset exceeds its sale price, particularly if the asset was not performing optimally or if market conditions for such assets were unfavorable.
The pro forma improvement in net loss attributable to OneWater Marine Inc. by $1.951 million suggests that Ocean Bio-Chem's operations, while contributing revenue, may have been a drag on overall profitability, making the divestiture a positive step for the remaining business's operational efficiency. This is a key indicator for investors assessing the strategic rationale of such a sale.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
D&O Indemnification Policy	The Purchaser will not materially and adversely amend, repeal or modify any provision in Group Company's Organizational Documents relating to the exculpation or indemnification of officers or directors for six years after closing, unless required by law.	2026-02-02	Ensures continued protection for past and present directors and officers of the divested entity, which is a standard practice in M&A transactions to mitigate personal liability risks.
D&O Tail Insurance Purchase	Seller or the Company will purchase an extended reporting period endorsement (D&O Tail) for six years after closing, covering claims prior to closing. The cost will be split 50/50 between Purchaser and Seller.	2026-02-02	Provides continuity of insurance coverage for former directors and officers, reducing potential post-closing liabilities for past actions and aligning with best practices in corporate governance during divestitures.

Legal Proceedings

The Seller will indemnify the Purchaser for Losses related to facts and circumstances arising from the litigation matters disclosed on Schedule 3.13 (schedule not provided in filing).

Related Party Transactions

All Related Party Transactions between any Group Company and the Seller or its affiliates (other than Group Companies) or related persons, as well as those with Contingent Workers or their related persons, are to be terminated effective immediately prior to the Closing, with no continuing liability for any Group Company.
Any intercompany receivables or payables between the Seller or its affiliates (other than Group Companies) and the Group Companies are to be automatically settled or released as of the Adjustment Calculation Time, subject to the Closing.

Stakeholder Impact

**Shareholders**: The sale and debt reduction could be viewed positively as a move to streamline operations and improve financial health, potentially leading to increased shareholder value through a more focused business and reduced financial risk. However, the one-time loss on sale might temper immediate enthusiasm.
**Creditors**: The use of proceeds to repay outstanding debt directly benefits creditors by reducing the company's leverage and improving its debt-servicing capacity.
**Employees**: The filing mentions that all employees performing services for the Business have been employed by Workforce Solutions and leased to the Group Companies. The Employee Leasing Agreement will be entered into on the Closing Date, suggesting a transition plan for personnel associated with Ocean Bio-Chem.
**Customers/Suppliers**: The divestiture of Ocean Bio-Chem means its customers and suppliers will now deal with Recochem Inc. OneWater Marine's core customers and suppliers are unlikely to be directly impacted, but the change in ownership for Ocean Bio-Chem could lead to new business dynamics for its specific stakeholders.

Next Steps

A final working capital true-up for the transaction will be determined 120 days after the Closing Date (February 2, 2026).
The Seller will pay the Purchaser any uncollected [*] Closing Aged Receivables remaining as of the first anniversary of the Closing Date.
OneWater Marine Inc. and its affiliates will cease using names including 'Ocean Bio-Chem', 'Star Brite', 'Kinpak', 'Odorstar' or derivatives thereof immediately after the Closing Date, except for the names of the Group Companies.

Key Dates

Date	Description
2021-01-01	Various compliance and historical look-back dates for representations and warranties.
2023-01-01	Historical look-back date for certain settlement agreements and related party transactions.
2024-09-30	Unaudited combined balance sheets and statements of operations for Group Operating Companies.
2024-10-01	Effective date for pro forma condensed consolidated statements of operations.
2025-01-01	Historical look-back date for employee and labor matters.
2025-09-02	Date of the Confidentiality Agreement between PFX Group Inc. and Truist Securities.
2025-09-30	Fiscal year end for pro forma condensed consolidated balance sheet and statements of operations; Latest Balance Sheet date for certain financial statements.
2025-11-21	Date of the letter of intent between Rocket Bidco, Inc., Seller, and Ocean Bio-Chem, LLC.
2025-11-30	Date of the unaudited combined balance sheet of the Group Operating Companies (Latest Balance Sheet).
2025-12-31	Date for the list of all inventory of the Group Companies.
2026-01-29	Date of the Bill of Sale, Assignment and Assumption Agreement for the YakGear Business.
2026-01-31	Adjustment Calculation Time (11:59 p.m. Eastern Time) for determining Closing Cash, Net Working Capital, and Indebtedness.
2026-02-01	Date of the Distribution and Redemption Agreement.
2026-02-02	Date of earliest event reported; Closing Date of the Securities Purchase Agreement and consummation of the sale.
2026-02-03	Outside Date for termination of the agreement if closing has not occurred.
2026-02-06	Date the Current Report on Form 8-K was signed.
2026-09-30	Date through which One Water Marine Holdings, LLC will maintain partnership status for US federal income tax purposes.
120 days after Closing Date	Period for final working capital true-up determination.
First anniversary of Closing Date	Payment due for any uncollected [*] Closing Aged Receivables.
Six (6) years after Closing	Survival period for Fundamental Representations and D&O liability insurance coverage.

Recommendation

hold

The sale of Ocean Bio-Chem is a strategic divestiture that allows OneWater Marine to reduce debt and focus on its core marine retail business. While there's a non-recurring loss on sale, the pro forma financials indicate an improvement in the company's net loss, suggesting enhanced operational efficiency for the remaining business. This move strengthens the balance sheet and provides a clearer strategic direction. However, the immediate accounting loss and the reduction in overall revenue base warrant a 'hold' recommendation, allowing investors to observe the execution of the refined strategy and the long-term benefits of a more focused operation.

Keywords

OneWater Marine, Ocean Bio-Chem, Recochem, Asset Sale, Divestiture, Debt Reduction, SEC Filing, 8-K, Financial Reporting, Pro Forma, Marine Industry

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.